IDH1 (Isocitrate Dehydrogenase) Antibody - With BSA and Azide
Mouse Monoclonal Antibody [Clone IDH1/1152 ]
|Application ||WB, IHC, IF, FC|
|Other Accession||3417, 593422|
|Isotype||Mouse / IgG1, kappa|
|Other Names||Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, 22.214.171.124, Cytosolic NADP-isocitrate dehydrogenase, IDP, NADP(+)-specific ICDH, Oxalosuccinate decarboxylase, IDH1, PICD|
|Storage||Store at 2 to 8°C.Antibody is stable for 24 months.|
|Precautions||IDH1 (Isocitrate Dehydrogenase) Antibody - With BSA and Azide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Cytoplasm. Peroxisome|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
It recognizes a 45kDa protein, which is identified as isocitrate dehydrogenase (IDH1). It belongs to the isocitrate and isopropylmalate dehydrogenases family. IDH1 catalyzes the third step of the citric acid cycle, which involves the oxidative decarboxylation of isocitrate, forming Ī �-ketoglutarate and CO2 in a two-step reaction. The first step involves the oxidation of isocitrate to the intermediate oxalosuccinate, while the second step involves the production of Ī �-ketoglutarate. During this process, either NADH or NADPH is produced along with CO2. Recently, an inactivating mutation of IDH1 has been implicated in glioblastoma. IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.
Geisbrecht, B.V. and Gould, S.J. 1999. The human PICD gene encodes a cytoplasmic and peroxisomal NADP+-dependent isocitrate dehydrogenase. J. Biol. Chem. 274: 30527-30533
If you have any additional inquiries please email technical services at firstname.lastname@example.org.